MedPath

Suction Drain Versus the Use of Adaptive Skin Sutures After Mastectomy ± Axillary Lymphadenectomy; a Prospective Randomised Study

Phase 3
Conditions
Invasive Breast Cancer
in Situ Breast Cancer
Interventions
Procedure: Adaptive skin sutures.
Procedure: Insertion of suction drain(s) following mastectomy
Registration Number
NCT01509781
Lead Sponsor
National Institute of Oncology, Hungary
Brief Summary

The objective of this prospective randomized study is to perform qualitative and quantitative comparisons between the insertion of traditional suction drains (Arm: Suction drain) versus the application of absorbable adaptive sutures (Arm: Adaptive suture) following simplex mastectomy or modified radical mastectomy in the light of the total volume of withdrawn serum from wound cavity, the extent of early postoperative analgesic requirements and quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
400
Inclusion Criteria
  • female patients with primary unilateral, stage 0, I or II, T3N1M0 breast cancer necessitating simple or modified radical mastectomy
Exclusion Criteria
  • age above 75 years and bad general state
  • pregnancy
  • autoimmune disease
  • non-radical excision
  • mastitis carcinomatosis
  • lymphangitis carcinomatosis
  • wound infection necessitating treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Adaptive sutureAdaptive skin sutures.Following mastectomy, wound cavity is closed with adaptive skin sutures. No suction drain is inserted.
Suction drainInsertion of suction drain(s) following mastectomyPatients in Arm A undergo simplex mastectomy or modified radical mastectomy. One plastic Redon drain (16 Ch) is placed after simplex mastectomy and two plastic Redon drains (16 Ch each) following modified radical mastectomy.
Primary Outcome Measures
NameTimeMethod
Total amount of sera withdrawn from the wound cavity4 weeks

By each follow-up visit within the indicated time frame, the punctuated serum is collected and its volume is measured by a measuring cylinder acquired from the Pharmacy Department and data is recorded. At the end of the follow-up period, the total amount of serum (mL) is documented.

Secondary Outcome Measures
NameTimeMethod
Extent of early postoperative analgesic requirements4 days

Assessment of analgesic consumption to achieve adequate pain relief for each patient. Pain relief is carried out according to institutional protocol and includes: diclofenac sodium, diclofenac sodium + orphenadrine, nalbuphine, metamizole sodium, paracetamole, tramadole.

Rate of local wound complications.4 weeks
Assessment of quality of life in the early postoperative period4 weeks

Using EORTC QoL BR23, weekly for 4 weeks following surgery.

Mobility of the shoulder on the side of the operated side4 weeks

Assessing shoulder motion on the 1st postoperative day, then weekly for 4 weeks.

Abduction 1: 0°- 45° Abduction 2: 45° - 90° Abduction 3: 90° - 135° Abduction 4: 135° - 180°

Number of punctions following the removal of suction drain, and total volume of punctuated seroma (mL)4 weeks
Cost analysis4 weeks

Suction drain, suction flask, syringes, number of patient-doctor consultations

Trial Locations

Locations (1)

National Institute of Oncology

🇭🇺

Budapest, Hungary

© Copyright 2025. All Rights Reserved by MedPath